Balyasny Asset Management L.P. Has $3.90 Million Stake in Option Care Health, Inc. (NASDAQ:OPCH)

Balyasny Asset Management L.P. lifted its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 338.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 168,082 shares of the company's stock after purchasing an additional 129,708 shares during the quarter. Balyasny Asset Management L.P. owned 0.10% of Option Care Health worth $3,900,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Murphy & Mullick Capital Management Corp acquired a new position in shares of Option Care Health in the fourth quarter valued at $26,000. UMB Bank n.a. raised its stake in shares of Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after purchasing an additional 346 shares in the last quarter. Signaturefd LLC raised its stake in shares of Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after purchasing an additional 1,005 shares in the last quarter. Quadrant Capital Group LLC raised its stake in shares of Option Care Health by 172.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after purchasing an additional 1,099 shares in the last quarter. Finally, Johnson Financial Group Inc. acquired a new position in shares of Option Care Health in the fourth quarter valued at $47,000. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

OPCH has been the subject of several recent analyst reports. Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and increased their price objective for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. JPMorgan Chase & Co. increased their price objective on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and increased their price objective for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. JMP Securities reiterated a "market outperform" rating and set a $36.00 price objective on shares of Option Care Health in a research note on Tuesday, April 22nd. Finally, Barrington Research reiterated an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research note on Wednesday, April 30th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $35.50.

Insider Activity at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. This trade represents a 40.80% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.64% of the stock is owned by company insiders.

Option Care Health Price Performance

Shares of OPCH stock traded up $0.23 during trading hours on Wednesday, hitting $31.79. 1,502,212 shares of the company's stock were exchanged, compared to its average volume of 1,854,974. The stock's 50-day moving average is $33.13 and its 200-day moving average is $28.92. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The stock has a market cap of $5.21 billion, a price-to-earnings ratio of 26.71, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.36 by $0.04. The company had revenue of $1.33 billion for the quarter, compared to analysts' expectations of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The business's revenue for the quarter was up 16.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.26 earnings per share. As a group, research analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.